Alstom has signed a bilateral agreement with the Israeli company Atlantium to expand the use of an innovative water treatment solution using ultraviolet rays (UV) in hydropower equipment. The technique destroys microorganisms that proliferate in the auxiliary water circuits of hydropower equipment…
How does the experience of using public transit compare around the world? How long do you wait for the bus or train? And, what frustrates you most along the way? We surveyed nearly 12,000 transit riders to find out. Transit takes…
Taboola, the leading content discovery platform, announced that it has completed a $117 million financing round led by Fidelity Management and Research Company, the investment adviser to Fidelity’s family of mutual funds. Also participating in the round are existing investors…
Building on their joint success of the spreading of Israel Science Information (paper version) on international lines, Air France and Israel Science Info magazine decided to extend their partnership. Since February 1, 2015, Air France offers the digital version of…
The funding round, led by EMC and Sequoia capital, is the company’s second in a year. Five million will be used to buy out some of the founders’ shares. Yet another funding round was announced in what is turning out…
MOND is a theory concerning the Dark Matter problem. The problem is that our observations of certain systems are inconsistent with Newtonian dynamics. We measure less mass than Newton’s law predicts there should be. There are 2 ways of looking…
The decline of the euro hampers Israeli exports to France, which remains the 10th largest customers of Israel and its 12th supplier. According to figures provided by the Israeli customs and taken over by the Institute of Statistics, changes in…
A team of researchers from the Tel Aviv University, Ben-Gurion University of the Negev and the Israel Antiquities Authority reported today in the new issue of Nature Magazine “one of the most important discoveries in the study of human evolution”.…
A collaborative study by researchers from Ben-Gurion University of the Negev, the National Institutes of Health in the USA and other institutions describes, for the first time, a novel molecular mechanism identified in human cells. The authors describe how proteins exploit the chloride…
Alpha1-antitrypsin (AAT) does a surprisingly good job killing bacteria, a research team at BGU, which has been studying the drug, has discovered. The recent study reported in the Journal of Infectious Diseases by the group headed by Dr. Eli C. Lewis “Acute Phase Protein α1-Antitrypsin Reduces Bacterial Burden…
